STEVEN JAY FRANK to Iodine Radioisotopes
This is a "connection" page, showing publications STEVEN JAY FRANK has written about Iodine Radioisotopes.
Connection Strength
3.098
-
Patient-reported health-related quality of life for men treated with low-dose-rate prostate brachytherapy as monotherapy with 125-iodine, 103-palladium, or 131-cesium: Results of a prospective phase II study. Brachytherapy. 2018 Mar - Apr; 17(2):265-276.
Score: 0.543
-
Establishing high-quality prostate brachytherapy using a phantom simulator training program. Int J Radiat Oncol Biol Phys. 2014 Nov 01; 90(3):579-86.
Score: 0.431
-
Impact of urinary catheterization on dosimetry after prostate implant brachytherapy with palladium-103 or iodine-125. Brachytherapy. 2011 Jul-Aug; 10(4):269-74.
Score: 0.337
-
Anisotropy characterization of I-125 seed with attached encapsulated cobalt chloride complex contrast agent markers for MRI-based prostate brachytherapy. Med Dosim. 2011; 36(2):200-5.
Score: 0.321
-
Prostogram predicted brachytherapy outcomes are not universally accurate: an analysis based on the M. D. Anderson Cancer Center experience with (125)iodine brachytherapy. J Urol. 2009 Apr; 181(4):1658-63; discussion 1663-4.
Score: 0.295
-
Is a loose-seed nomogram still valid for prostate brachytherapy in a stranded-seed era? Int J Radiat Oncol Biol Phys. 2008 Oct 01; 72(2):623-7.
Score: 0.278
-
Predictors of urinary toxicity with MRI-assisted radiosurgery for low-dose-rate prostate brachytherapy. Brachytherapy. 2020 Sep - Oct; 19(5):574-583.
Score: 0.162
-
MRI-assisted radiosurgery: A quality assurance nomogram for palladium-103 and iodine-125 prostate brachytherapy. Brachytherapy. 2020 Jan - Feb; 19(1):38-42.
Score: 0.156
-
Sexual function and the use of medical devices or drugs to optimize potency after prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2012 Apr 01; 82(5):e765-71.
Score: 0.090
-
Displacement of periurethral stranded seeds and its dosimetric consequences in prostate brachytherapy. Brachytherapy. 2011 Sep-Oct; 10(5):401-8.
Score: 0.084
-
The impact of acute urinary retention after iodine-125 prostate brachytherapy on health-related quality of life. Int J Radiat Oncol Biol Phys. 2010 Aug 01; 77(5):1322-8.
Score: 0.078
-
Long-term biochemical and survival outcome of 921 patients treated with I-125 permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2010 Apr; 76(5):1433-8.
Score: 0.075
-
An assessment of quality of life following radical prostatectomy, high dose external beam radiation therapy and brachytherapy iodine implantation as monotherapies for localized prostate cancer. J Urol. 2007 Jun; 177(6):2151-6; discussion 2156.
Score: 0.065
-
Interstitial implant alone or in combination with external beam radiation therapy for intermediate-risk prostate cancer: a survey of practice patterns in the United States. Brachytherapy. 2007 Jan-Mar; 6(1):2-8.
Score: 0.063
-
Outcomes after PD-103 versus I-125 for low dose rate prostate brachytherapy monotherapy: An international, multi-institutional study. Radiother Oncol. 2023 06; 183:109599.
Score: 0.049
-
Evaluation of the MIM Symphony treatment planning system for low-dose-rate- prostate brachytherapy. J Appl Clin Med Phys. 2015 09 08; 16(5):62?75.
Score: 0.029
-
Prostate specific antigen bounce is related to overall survival in prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2012 Feb 01; 82(2):883-8.
Score: 0.021
-
Health-related quality of life up to six years after (125)I brachytherapy for early-stage prostate cancer. Int J Radiat Oncol Biol Phys. 2010 Mar 15; 76(4):1054-60.
Score: 0.020